Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus O Butler

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Immunological Reviews|December 17, 2013
Human cell-based artificial antigen-presenting cells for cancer immunotherapyMarcus O Butler, Naoto Hirano
JCO Oncology Practice|June 27, 2022
Reply to M.Z. Farooq et alDiana P Arteaga, Marcus O Butler
Journal for Immunotherapy of Cancer|August 20, 2015
PembrolizumabLeila Khoja, Marcus O Butler, S Peter Kang, et al.
British Journal of Haematology|January 11, 2005
Presence of anti-kinectin and anti-PMS1 antibodies in Japanese aplastic anaemia patientsNaoto Hirano, Marcus O Butler, Eva C Guinan, et al.
Nature Medicine|October 6, 2022
Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global accessIan Hirsch, Daniel A Goldstein, Ian F Tannock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2011
Induction of HLA-DP4-restricted anti-survivin Th1 and Th2 responses using an artificial antigen-presenting cellMakito Tanaka, Marcus O Butler, Sascha Ansén, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Dissociation of its opposing immunologic effects is critical for the optimization of antitumor CD8+ T-cell responses induced by interleukin 21Sascha Ansén, Marcus O Butler, Alla Berezovskaya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2006
Efficient presentation of naturally processed HLA class I peptides by artificial antigen-presenting cells for the generation of effective antitumor responsesNaoto Hirano, Marcus O Butler, Zhinan Xia, et al.
Plos One|May 24, 2016
Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell ReceptorsTingxi Guo, Kenji Chamoto, Munehide Nakatsugawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2015
Specific roles of each TCR hemichain in generating functional chain-centric TCRMunehide Nakatsugawa, Yuki Yamashita, Toshiki Ochi, et al.
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Immunological Reviews|December 17, 2013
Human cell-based artificial antigen-presenting cells for cancer immunotherapyMarcus O Butler, Naoto Hirano
JCO Oncology Practice|June 27, 2022
Reply to M.Z. Farooq et alDiana P Arteaga, Marcus O Butler
Journal for Immunotherapy of Cancer|August 20, 2015
PembrolizumabLeila Khoja, Marcus O Butler, S Peter Kang, et al.
British Journal of Haematology|January 11, 2005
Presence of anti-kinectin and anti-PMS1 antibodies in Japanese aplastic anaemia patientsNaoto Hirano, Marcus O Butler, Eva C Guinan, et al.
Nature Medicine|October 6, 2022
Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global accessIan Hirsch, Daniel A Goldstein, Ian F Tannock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2011
Induction of HLA-DP4-restricted anti-survivin Th1 and Th2 responses using an artificial antigen-presenting cellMakito Tanaka, Marcus O Butler, Sascha Ansén, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Dissociation of its opposing immunologic effects is critical for the optimization of antitumor CD8+ T-cell responses induced by interleukin 21Sascha Ansén, Marcus O Butler, Alla Berezovskaya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2006
Efficient presentation of naturally processed HLA class I peptides by artificial antigen-presenting cells for the generation of effective antitumor responsesNaoto Hirano, Marcus O Butler, Zhinan Xia, et al.
Plos One|May 24, 2016
Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell ReceptorsTingxi Guo, Kenji Chamoto, Munehide Nakatsugawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2015
Specific roles of each TCR hemichain in generating functional chain-centric TCRMunehide Nakatsugawa, Yuki Yamashita, Toshiki Ochi, et al.
Pageof 13